Posted on May 4, 2010 by Sitemaster
The role of PSA kinetics (i.e., PSA doubling time and PSA velocity) in the early diagnosis of prostate cancer and in the monitoring of patients on active surveillance protocols has been controversial. We now have some more definitive data. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, doubling time, kinetics, PSA, PSADT, PSAV, velocity | 6 Comments »
Posted on September 18, 2009 by Sitemaster
In today’s news reports we have focused primarily on data showing that specific things do not seem to work well in prostate cancer risk assessment and diagnosis:
- Neither PSA velocity nor the PSA/serum testosterone ratio are normally predictive for risk of prostate cancer in undiagnosed patients.
- Post-surgical tumor volume is not predictive for risk of prostate cancer progression.
- A new nomogram predicts risk of pathological upgrading post-surgery. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: free PSA, PSA, PSA velocity, PSAV, ratio, testosterone | 1 Comment »